Results 61 to 70 of about 1,046,073 (109)
Some of the next articles are maybe not open access.
New drug approvals in oncology
Nature Reviews Clinical Oncology, 2020The traditional regulatory drug approval paradigm comprising discrete phases of clinical testing that culminate in a large randomized superiority trial has historically been predominant in oncology. However, this approach has evolved in the current era of drug development, with multiple other development pathways now being utilized.
Razelle, Kurzrock +3 more
openaire +2 more sources
Nature Reviews Drug Discovery, 2017
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire +2 more sources
FDA approval count fell last year, despite a steady regulatory filing rate. FDA approval count fell last year, despite a steady regulatory filing rate.
openaire +2 more sources
Drug Approval Highlights for 2003
The Nurse Practitioner, 2004In the past 12 months, the FDA has approved important new pharmaceutical drugs and devices of particular interest to primary health care providers. The drugs include: Oxytrol (for urinary incontinence), Valtrex (for reducing the risk of heterosexual transmission of genital herpes), Femring (for vaginal delivery of hormone therapy), Uroxatral (for ...
Laustsen, Gary, Wimett, Lynn
openaire +2 more sources
Tardive Dyskinesia Drug Approved
JAMA, 2017The first drug for adults with tardive dyskinesia (TD) has received FDA approval. Tardive dyskinesia is a neurological disorder that causes repetitive, involuntary movements such as abnormal tongue and lip movements, cheek bulging, foot tapping, shoulder shrugging, and rocking and swaying movements.
openaire +2 more sources
The Nurse Practitioner, 2014
This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.
openaire +2 more sources
This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.
openaire +2 more sources
Accelerating drug development and approval
Drug News & Perspectives, 2010Regulatory agencies are the gateway between the pharma/biotech industry and patients and can serve as stimulators of new drug development. This article highlights several means of doing so implemented thus far, many with already impressive histories, such as orphan drug legislation, and others of a more experimental nature, such as the FDA's priority ...
openaire +2 more sources
Non-Approved Use of Food and Drug Administration Approved Drugs
American Journal of Ophthalmology, 1979J S, Mindel, J I, Goldstein
openaire +2 more sources